DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Weitz JI, Cao C, Eriksson BI. , et al.
A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
Thromb Haemost 2010;
104 (06) 1150-1157
We do not assume any responsibility for the contents of the web pages of other providers.